Abstract
The phenotypic effects of aberrant gene expression are indistinguishable, regardless of whether the underlying mutation is one of gene copy number (deletion or duplication) or modification of differentially methylated CpG sites occurring in critical regulatory sequences in gene promoters. The XLnt photocrosslinking oligonucleotide technology provides for the hybridizatio-dependent covalent attachment of probe to target, allowing survival of the probe/target complex under otherwise denaturing conditions. Posthybridization wash stringency can be substantially higher than under standard techniques, leading to a marked increase in signal-to-noise ratios. In addition, the reduction in nonspecific background provides linearity to XLnt-based oligonucleotide assays comparable to that otherwise achieved only with very long probes. The technology is thus ideally suited for combining the high-throughput capacity of oligonucleotide hybridization platforms with accurate measurement of relative gene dosage. By integrating the XLnt system with an assay design separating probe/target immobilization and signal elaboration functions, relative gene dosage assessment can be applied to the quantitation of fractional resistance to methylation-sensitive restriction enzyme (MSRE) digestion. The method described below provides for the development of photocrosslinking oligonucleotide assays for relative gene dosage and fractional locus CpG methylation in a microtiter plate-based format.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chan, H. L. Y., Leung, N. W. Y., Lau, T. C. M., Wong, M. L., and Sung, J. J. Y. (2000) Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy. J. Clin. Microbiol. 38, 3205–3208.
Zehnder, J., Van Atta, R., Jones, C, Sussmann, H., and Wood, M. (1997) Cross-linking hybridization assay for direct detection of factor V Leiden mutation. Clin. Client. 43, 1703–1708.
Wylenzek, C, Engelmann, M., Holten, D., Van Atta, R., Wood, M., and Gathof, B. (2000) Evaluation of a nucleic acid-based cross-linking assay to screen for hereditary hemochromatosis in healthy blood donors. Clin. Chem. 46, 1853–1855.
Huan, B., Van Atta, R., Cheng, P., Wood, M. L., Zychlinsky, E., and Albagli, D. (2000) Photo-Cross-Linkable Oligonucleotide Probes for In Situ Hybridization Assays. BioTechniques 28, 254–260.
French, C, Li, C, Strom, C, Sun, W., Van Atta, R., Gonzalez, B. and Wood, M. Detection of the factor V leiden mutation by a modified photo cross-linking oligonucleotide hybridization assay. Clin. Chem. 50, 296–305.
Peoples, R., Weltman, H., Van Atta, R., Wang, J., Wood, M., Ferrante-Raimondi, M., Cheng, P., and Huan, B. (2002) High-throughput detection of submicroscopic deletions and methylation status at 15q11–q13 by a photo-cross-linking oligonucleotide hybridization assay. Clin. Chem. 48, 1844–1850.
Snijders, A. M., Nowak, N., Segraves, R., et al. (2001) Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29, 263,264.
Mitelman, F., Johansson, B., and Mertens, F., eds. Mitelman Database of Chromosome Aberrations in Cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Peoples, R., Wood, M., Van Atta, R. (2004). Photocrosslinking Oligonucleotide Hybridization Assay for Concurrent Gene Dosage and CpG Methylation Analysis. In: Tollefsbol, T.O. (eds) Epigenetics Protocols. Methods in Molecular Biology™, vol 287. Humana Press. https://doi.org/10.1385/1-59259-828-5:233
Download citation
DOI: https://doi.org/10.1385/1-59259-828-5:233
Publisher Name: Humana Press
Print ISBN: 978-1-58829-336-7
Online ISBN: 978-1-59259-828-1
eBook Packages: Springer Protocols